Natera, Inc.

  • Moat Score
  • Safety Score
  • Market Cap $20.94B
  • PE -98
  • Debt $367.02M
  • Cash $892.84M
  • EV $20.42B
  • FCF -$33.19M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$214.69M
EBIT-$212.45M
ROE-24%
ROA-13%
FCF-$33.19M
Equity$878.53M
Growth Stability1
PE-97.55
PB23.84
P/FCF-631.12
P/S13.67
Price/Cash0.04
Debt/Equity0.42
Debt/FCF-11.06
Net Margins-11%
Op. Margins-14%
Sales Growth YoY64%
Sales Growth QoQ6%
Sales CAGR27%
Equity CAGR32%
Earnings Growth YoY-71%
Earnings Growth QoQ-16%
Sales CAGR 5Y40%
Equity CAGR 5Y25%
Earnings CAGR 3Y36%
Sales CAGR 3Y36%
Equity CAGR 3Y24%
Market Cap$20.94B
Revenue$1.53B
Assets$1.59B
Total Debt$367.02M
Cash$892.84M
Shares Outstanding122.01M
EV20.42B
Moat Score4%
Safety Score69%
Working Capital1.02B
Current Ratio4.39
Shares Growth 3y12%
Equity Growth QoQ5%
Equity Growth YoY12%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result.

SEC Filings

Direct access to Natera, Inc. (NTRA) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Natera, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Natera, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Natera, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Natera, Inc..

= -$332M
012345678910TV
fcf-$33M-$33M-$33M-$33M-$33M-$33M-$33M-$33M-$33M-$33M-$33M-$332M
DCF-$30M-$27M-$25M-$23M-$21M-$19M-$17M-$15M-$14M-$13M-$128M
Value-$332M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins-3%-37%-44%-65%-50%-41%-59%-75%-67%-40%-11%
ROA--23%-45%-75%-43%-20%-23%-38%-39%-30%-13%
ROE--38%-90%1K%-398%-45%-47%-72%-78%-57%-24%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF--0.92-0.51-1.15-1.66-1.83-1.25-0.9-0.77-1.29-11.06
Debt over Equity-0.020.230.47-11.883.840.450.520.520.520.480.42
Growth Stability----------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-20%14%-3%22%17%29%60%31%32%40%
Earnings YoY growth-1K%36%42%-6%-3%84%105%16%-21%-
Equity YoY growth--208%-42%-110%-410%767%74%34%8%8%25%
FCF YoY growth--9K%112%10%-30%-8%195%86%27%-40%-